Augustina Isioma Ikusemoro: Thalassaemia is Not Just Anaemia – It’s a Genetic Story That Shapes
Augustina Isioma Ikusemoro, Hematology and Transfusion Medicine Specialist at Sharjah Blood Transfusion and Research Center, shared a post on LinkedIn:
“Thalassaemia: It’s not just anaemia – it’s a genetic story that shapes outcomes.
Behind every microcytic blood film lies a deeper question:
Is this iron deficiency… or something inherited?
Thalassaemia is a disorder of globin chain synthesis, where the body cannot produce normal amounts of alpha or beta globin chains, leading to ineffective red cell production and varying degrees of anaemia.
Here’s what truly matters clinically:
The genetics define the disease
- Alpha-globin genes are located on chromosome 16
- Beta-globin genes are located on chromosome 11
Most α-thalassaemia cases are caused by gene deletions.
This is a key distinction – especially when interpreting microcytosis with normal iron studies.
Severity depends on how many gene copies are affected:
- Loss of 1–2 genes leads to mild or asymptomatic
- Loss of 3 genes leads to moderate to severe disease
- Loss of all 4 genes leads to Hydrops fetalis (Hb Bart’s) — often fatal without intervention
This is why thalassaemia should never be approached as ‘just another anaemia.’
It requires:
- Understanding of genetic patterns
- Correlation with RBC indices and Hb analysis
- Awareness of population risk and inheritance patterns
Because accurate diagnosis is not just academic – it directly impacts:
- Patient management
- Genetic counselling
- Prenatal outcomes
The real takeaway?
- Don’t just treat anaemia.
- Understand the biology behind it.
When you understand the genes, you diagnose with precision.
— Signature of Blood Doki
Educate.
Empower.
Elevate.”
Find more posts featuring Augustina Isioma Ikusemoro on Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers